MYCN and neuroblastoma: Notably, our analysis highlighted two groups of MAP genes: G1 group (62 genes), which showed increased expression in concordance with MYCN amplification; and G2 group (14 genes), which was uniquely associated with NB tumors without MYCN amplification but with high clinical risk (Figure 2D).